发明授权
US06124323A 4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists 失效
4-取代的哌啶类似物及其作为亚型选择性NMDA受体拮抗剂的用途

4-substituted piperidine analogs and their use as subtype selective NMDA
receptor antagonists
摘要:
Novel 4-substituted piperidine analogs, pharmaceutical compositions containing the same and the method of using 4-substituted piperidine analogs are selective active antagonists of N-methyl-D-aspartate (NMDA) receptor subtypes for treating conditions such as stroke, cerebral ischemia, central nervous system trauma, hypoglycemia, psychosis, anxiety, migraine headaches, glaucoma, CMV retinitis, aminoglycoside antibiotics-induced hearing loss, convulsions, chronic pain, opioid tolerance or withdrawal, urinary incontinence or neurodegenerative disorders, such as lathyrism, Alzheimer's Disease, Parkinsonism and Huntington's Disease are described.
公开/授权文献
信息查询
0/0